Cargando…

Drug Management of Prostate Cancer

This book is a comprehensive, concise summary of the pharmacological treatments of prostate cancer. It is an authoritative and up-to-date reference on therapeutic options involving both standard of care and investigational agents. The chapters describe state of the art information on Hormone Therapy...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Figg, William D. (Editor ), Chau, Cindy H. (Editor ), Small, Eric J. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2010.
Edición:1st ed. 2010.
Temas:
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Cell Biology of Prostate Cancer and Molecular Targets
  • Cell Biology of Prostate Cancer and Molecular Targets
  • Hormone Therapy
  • Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer
  • Nuclear Receptor Coregulators: Promising Therapeutic Targets for the Treatment of Prostate Cancer
  • Androgens and Prostate Cancer
  • Androgen Receptor Biology in Prostate Cancer
  • Androgen Receptor Antagonists
  • 5-Alpha Reductase Inhibitors in Prostate Cancer
  • Adrenal Androgen Synthesis Inhibitor Therapies in Castration-Resistant Prostate Cancer
  • Androgen Deprivation Therapy
  • Pharmacogenetics of the Androgen Metabolic Pathway
  • Chemotherapy
  • Mitoxantrone
  • Docetaxel
  • Beyond Docetaxel: Emerging Agents in the Treatment of Advanced Prostate Cancer
  • Platinum Agents in Prostate Cancer
  • Clinical Pharmacology and Pharmacogenetics of Chemotherapy in Prostate Cancer
  • Microtubule Targeting Agents
  • Angiogenesis
  • Principles of Antiangiogenic Therapy
  • Bevacizumab in Advanced Prostate Cancer
  • Thalidomide and Analogs
  • Investigational Angiogenesis Inhibitors
  • Pharmacogenetics of Angiogenesis
  • Bone Metastasis
  • Pathophysiology of Prostate Cancer Bone Metastasis
  • Radiopharmaceuticals
  • Bisphosphonates for Prevention and Treatment of Bone Metastases
  • Endothelin Receptors as Therapeutic Targets in Castration-Resistant Prostate Cancer
  • Calcitriol and Vitamin D Analogs
  • Immunotherapy
  • Cancer Immunology, Immunotherapeutics, and Vaccine Approaches
  • Sipuleucel-T: Autologous Cellular Immunotherapy for Metastatic Castration-Resistant Prostate Cancer
  • GM-CSF Gene-Transduced Prostate Cancer Vaccines: GVAX
  • CTLA-4 Blockade for Prostate Cancer Treatment
  • Prevention
  • Prostate Cancer Chemoprevention Strategies
  • Diet and Prostate Cancer Incidence, Recurrence, and Progression Risk
  • Inflammation as a Target in Prostate Cancer
  • Drug Development
  • Challenges for the Development of New Agents in Prostate Cancer
  • FDA Approval of Prostate Cancer Treatments
  • Applications of Proteomics in Prostate Cancer
  • Erratum to: Docetaxel
  • Erratum to: Docetaxel.